Bristol-Myers
Squibb
Corporate Profile
BMS Canada is one of the nation's largest pharmaceutical
and healthcare companies, with over 1,000 employees and a
number of locations across the country. Four business units
represent BMS: the Bristol-Myers Squibb Pharmaceutical group,
Mead Johnson, BMS Medical Imaging and ConvaTec. The BMS Pharmaceutical
Research Institute has a facility in Quebec that does basic
research and produces medication for clinical trials in over
85 countries.
Bristol-Myers Squibb was first established in Canada in 1948
and has expanded its activities through the acquisition of
Squibb & Sons in 1989 and DuPont Pharmaceuticals in 2001.
Bristol-Myers Squibb is a worldwide pharmaceutical company
with important related health care businesses with sales of
$19 billion whose principal businesses are pharmaceuticals,
radio pharmaceuticals and nutritionals. Its headquarters are
located in Princeton, New Jersey.
|
PRESIDENT AND GENERAL MANAGER
:
Mr. Wayne Quigley
NO. OF EMPLOYEES :
over 1,000
SALES:
$19 billion (worldwide)
|
THERAPEUTIC CATEORIES :
The BMS Pharmaceutical Group is
a leading maker of innovative therapies in the following
therapeutic areas:
· cardiovascular
· HIV/Aids
· cancer
· metabolic and infectious diseases
· central nervous system
· dermatological disorders.
|
|
Quick Facts
 CORPORATE
ENTITY
Bristol-Myers Squibb is committed to ongoing
research that will continue to extend and enhance the lives
of Canadians.
CANADIAN
HEAD OFFICE
2365 Côte de Liesse Road
Montreal, Quebec H4N 2M7
Tel: (514) 333-3200
Fax: (514) 335-4102
Internet address: www.bmscanada.ca
OUR
MISSION
To Extend and enhance human life
|
